Galimidi, Rachel P.
- Wang, Haoqing and Gristick, Harry B., et el. (2017) Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies; eLife; Vol. 6; Art. No. e27389; PMCID PMC5472438; 10.7554/eLife.27389.001
- Kieffer, Collin and Ladinsky, Mark S., et el. (2017) Longitudinal imaging of HIV-1 spread in humanized mice with parallel 3D immunofluorescence and electron tomography; eLife; Vol. 6; Art. No. e23282; PMCID PMC5338924; 10.7554/eLife.23282
- Wang, Haoqing and Cohen, Alexander A., et el. (2016) Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop; Proceedings of the National Academy of Sciences of the United States of America; Vol. 113; No. 46; E7151-E7158; PMCID PMC5135367; 10.1073/pnas.1615939113
- Marshall, Stephen S. and Niesen, Michiel J. M., et el. (2016) A Link between Integral Membrane Protein Expression and Simulated Integration Efficiency; Cell Reports; Vol. 16; No. 8; 2169-2177; PMCID PMC5001948; 10.1016/j.celrep.2016.07.042
- Mehta, Arnav and Zhao, Jimmy L., et el. (2015) The MicroRNA-132 and MicroRNA-212 Cluster Regulates Hematopoietic Stem Cell Maintenance and Survival with Age by Buffering FOXO3 Expression; Immunity; Vol. 42; No. 6; 1021-1032; PMCID PMC4471877; 10.1016/j.immuni.2015.05.017
- Barbian, Hannah J. and Galimidi, Rachel P., et el. (2015) Neutralization Properties of Simian Immunodeficiency Viruses Infecting Chimpanzees and Gorillas; mBio; Vol. 6; No. 2; Art. No. e00296; PMCID PMC4453581; 10.1128/mBio.00296-15
- Galimidi, Rachel P. and Klein, Joshua S., et el. (2015) Intra-Spike Crosslinking Overcomes Antibody Evasion by HIV-1; Cell; Vol. 160; No. 3; 433-446; PMCID PMC4401576; 10.1016/j.cell.2015.01.016
- Klein, Joshua S. and Jiang, Siduo, et el. (2014) Design and characterization of structured protein linkers with differing flexibilities; Protein Engineering, Design and Selection; Vol. 27; No. 10; 325-330; PMCID PMC4191447; 10.1093/protein/gzu043
- Galimidi, R. P. and West, A. P., et el. (2013) Thwarting HIV Evasion of Antibody Avidity with Novel Antibody Architectures; AIDS Research and Human Retroviruses; Vol. 29; No. 11; A140-A141; 10.1089/aid.2013.1500
- Galimidi, Rachel and West, Anthony, et el. (2013) Thwarting HIV evasion of antibody avidity with novel antibody architectures; Journal of Immunology; Vol. 190; 179.7
- Parrish, Nicholas F. and Galimidi, Rachel P., et el. (2013) Phenotypic properties of transmitted founder HIV-1; Proceedings of the National Academy of Sciences of the United States of America; Vol. 110; No. 17; 6626-6633; PMCID PMC3637789; 10.1073/pnas.1304288110
- Yu, Kenneth K. and Aguilar, Kiefer, et el. (2012) Use of Mutated Self-Cleaving 2A Peptides as a Molecular Rheostat to Direct Simultaneous Formation of Membrane and Secreted Anti-HIV Immunoglobulins; PLoS ONE; Vol. 7; No. 11; Art. No. e50438; PMCID PMC3508920; 10.1371/journal.pone.0050438
- West, Anthony P., Jr. and Galimidi, Rachel P., et el. (2012) Single-Chain Fv-Based Anti-HIV Proteins: Potential and Limitations; Journal of Virology; Vol. 86; No. 1; 195-202; PMCID PMC3255864; 10.1128/JVI.05848-11
- Klein, Joshua S. and Webster, Alexandre, et el. (2010) A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity; AIDS; Vol. 24; No. 11; 1633-1640; PMCID PMC2898891; 10.1097/QAD.0b013e32833ad8c8
- West, Anthony P., Jr. and Galimidi, Rachel P., et el. (2010) Evaluation of CD4-CD4i Antibody Architectures Yields Potent, Broadly Cross-Reactive Anti-Human Immunodeficiency Virus Reagents; Journal of Virology; Vol. 84; No. 1; 261-269; PMCID PMC2798438; 10.1128/JVI.01528-09
- Klein, Joshua S. and Gnanapragasam, Priyanthi N. P., et el. (2009) Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10; Proceedings of the National Academy of Sciences of the United States of America; Vol. 106; No. 18; 7385-7390; PMCID PMC2678646; 10.1073/pnas.0811427106
- West, Anthony P., Jr. and Galimidi, Rachel P., et el. (2009) Design and Expression of a Dimeric Form of the Human Immunodeficiency Virus Type 1 Antibody 2G12 with Increased Neutralization Potency; Journal of Virology; Vol. 83; No. 1; 98-104; PMCID PMC2612297; 10.1128/JVI.01564-08